Paget's disease of bone, also known as osteodystrophy or osteitis deformans, is a chronic skeletal disorder characterized by abnormal bone remodeling. This results in enlarged and deformed bones, usually in areas such as the pelvis, skull, spine, and limbs. Both osteoblasts and osteoclasts are involved, causing an imbalance between bone formation and resorption. This process results in uneven bone growth, which can cause pain, osteoarthritis, fractures, and even cardiovascular problems due to increased stress on major blood vessels. Paget's disease can progress without symptoms for many years, but in some cases, severe symptoms prompt the patient to seek medical attention.
History of the disease and interesting historical facts
Paget's disease was first described by the English physician James Paget in 1877, who noticed characteristic changes in the bones of several patients. His name is most often associated with this pathology, but the disease was known earlier, although not under this name. Interestingly, Paget himself suffered from the disease, which may have influenced his research interest in this pathology. Throughout the 20th century, many discoveries were made regarding the pathophysiology and genetic predisposition to the disease. Despite medical advances, many aspects of Paget's disease remain poorly understood.
Epidemiology
Epidemiological studies show that Paget's disease is most common in older age groups, mainly in people over 50 years of age. According to various studies, the prevalence of the disease ranges from 1% to 3% in people over 55 years of age in regions with low geographic mobility. For example, in the UK, the prevalence is about 1-2.5% in people over 50 years of age. At the same time, in some regions of Europe, such as Italy and France, the incidence is higher: it can reach 8%. Women suffer from the disease more often than men, but men have more pronounced clinical manifestations.
Genetic predisposition to this disease
Studies show that the presence of Paget's disease may be associated with a genetic predisposition. Active work is needed to identify the genes involved in the development of this disease. In particular, it was found that mutations in the SQSTM1 and RANK genes may predispose to the disease. The SQSTM1 gene encodes a protein involved in the degradation of signaling molecules, which affects the interaction of osteoblasts and osteoclasts. In addition, the RANK gene, involved in the activation of osteoclasts, is also associated with these genetic factors. Hereditary cases of Paget's disease confirm its genetic link, which opens new horizons for understanding the pathogenesis and developing treatment methods.
Risk factors for the development of this disease
Risk factors for Paget's disease include both environmental and genetic factors. The main physical and chemical factors include:
- Age: Increased risk is seen in older adults.
- Gender: Men are more susceptible to the disease than women.
- Genetic predisposition: presence of diseases among close relatives.
- Northern European ethnicity: higher prevalence among this group.
- Injuries: Some studies suggest a link between injuries and the development of the disease.
Diagnosis of this disease
Paget's disease is diagnosed by evaluating clinical symptoms, laboratory and radiological examinations. The main symptoms include:
- Pain in bones and joints.
- Unusual skeletal deformities.
- Limitation of movement.
- Signs of osteoarthritis.
Laboratory tests may include measuring alkaline phosphatase levels, which are usually elevated in patients with the disease. Radiological tests, such as X-rays and MRIs, can help identify changes in bone tissue. It is also important to differentiate other diseases, such as osteoporosis and osteosarcoma, to establish an accurate diagnosis.
Treatment
Treatment of Paget's disease may include both medical and surgical approaches. The main areas of therapy are:
- General treatment: gentle physical activity to maintain the function of the knee and hip joints.
- Pharmacological treatment: use of bisphosphonates such as zoledronic acid and alendronate to reduce osteoclast activity.
- Surgical treatment: indicative in the presence of complex deformities or fractures.
- Other treatments include using anti-inflammatory drugs to relieve pain.
List of medications used to treat this disease
The main drugs used to treat Paget's disease include:
- Bisphosphonates (zoledronic acid, alendronate).
- Calcitonin.
- Parathyroid hormone.
- Nonsteroidal anti-inflammatory drugs.
Disease monitoring
The patient's condition should be monitored regularly, with an emphasis on monitoring alkaline phosphatase levels and assessing clinical symptoms. The prognosis in most cases can be favorable if treatment is started promptly, but complications including spinal stenosis, osteosarcomas, and fractures are possible. Monitoring of bone health after completion of treatment is mandatory.
Age-related features of the disease
Paget's disease manifests itself differently in different age groups. In younger patients (under 50 years), the disease may progress more aggressively and cause serious complications. In older patients, the disease is often asymptomatic, and changes are detected incidentally during routine examinations. In women, the disease may be less pronounced than in men, but clinical cases vary.
Questions and Answers
- What causes Paget's disease? The main cause of Paget's disease is considered to be a mutation in genes associated with osteoclasts and osteoblasts. Age and genetic factors can also influence the disease.
- What are the symptoms of Paget's disease? The main symptoms include bone pain, deformities and limited joint mobility.
- How is Paget's disease treated? Treatment includes pharmacological therapy using bisphosphonates and surgery when necessary.
- What is the life expectancy of a person with Paget's disease? With adequate treatment, the prognosis is usually good, but complications are possible that can affect quality of life.
- Can Paget's disease cause fractures? Yes, bone deformities caused by the disease can increase the risk of fractures.
